Arsenite suppresses IL-2-dependent tumoricidal activities of natural killer cells

Toxicol Appl Pharmacol. 2021 Feb 1:412:115353. doi: 10.1016/j.taap.2020.115353. Epub 2020 Dec 8.

Abstract

Chronic exposure to arsenic causes cancers in various organs including the skin, liver, lung, and bladder in humans, but the mechanisms of the multi-organ carcinogenicity of arsenic remain unknown. Natural killer (NK) cells play important roles in the immune surveillance and elimination of tumor cells. Although accumulating evidence has indicated that arsenic has immunosuppressive properties, little is known about the effects of arsenic on the tumoricidal functions of NK cells. We examined the effects of arsenite on the cytotoxic activities of human and mouse NK cells toward target tumor cells. Exposure of human NK-92 cells and primary mouse NK cells to sublethal doses of arsenite reduced the IL-2-activated cytotoxic activities toward human K562 cells and murine YAC-1 cells, respectively. NK cells recognize target cells via integrated signals from both activating and inhibitory receptors and induce apoptosis of target cells via a granzyme/perforin system. We found that exposure of NK-92 cells to arsenite diminished the IL-2-activated down-regulation of the inhibitory receptors, KIR2DL2 and KIR2DL3, and the up-regulation of granzyme B and lymphotoxin-α. The IL-2-activated increases in secretion of interferon-γ and IL-10 were also slightly reduced by arsenite. Thus, arsenite suppressed the IL-2-activated cytotoxic activity of NK cells by disrupting multiple pathways required for the recognition and killing of target tumor cells. Our findings provide new insights into the roles of NK cell-mediated tumor immunity in cancer development by arsenic.

Keywords: Arsenic; Carcinogenesis; Granzyme; Inhibitory receptor; Natural killer cell; Tumor immunity; Tumoricidal activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arsenites / toxicity*
  • Coculture Techniques
  • Cytotoxicity, Immunologic / drug effects*
  • Granzymes / genetics
  • Granzymes / metabolism
  • Humans
  • Interferon-gamma / genetics
  • Interferon-gamma / metabolism
  • Interleukin-10 / metabolism
  • Interleukin-2 / pharmacology*
  • K562 Cells
  • Killer Cells, Natural / drug effects*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Lymphotoxin-alpha / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Receptors, KIR2DL2 / genetics
  • Receptors, KIR2DL2 / metabolism
  • Receptors, KIR2DL3 / genetics
  • Receptors, KIR2DL3 / metabolism
  • Sodium Compounds / toxicity*
  • Tumor Escape / drug effects*

Substances

  • Arsenites
  • Interleukin-2
  • Lymphotoxin-alpha
  • Receptors, KIR2DL2
  • Receptors, KIR2DL3
  • Sodium Compounds
  • Interleukin-10
  • sodium arsenite
  • Interferon-gamma
  • Granzymes